An open-label, pilot study of veliparib and lapatinib in patients with metastatic, triple-negative breast cancer

Overview of attention for article published in Breast Cancer Research, March 2021

Altmetric Badge

Mentioned by

So far, Altmetric has seen 1 X post from an account with 884 followers.

An open-label, pilot study of veliparib and lapatinib in patients with metastatic, triple-negative breast cancer https://t.co/PSc9G5OJKF

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.